Chan Mitchell (CIK 1789335) reported 5 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-09-03). Recent activity: Sell RGNX (4,902 shares), Sell AVTX (3,167 shares), Buy AVTX (3,166 shares), Buy RGNX (73,749 shares), Sell RGNX (4,901 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-03 | REGENXBIO Inc. (RGNX) | Chief Financial Officer | Sell | 4,902 | $45,687 |
| 2026-05-07 | Avalo Therapeutics, Inc. (AVTX) | Director | Sell | 3,167 | $72,461 |
| 2026-03-31 | Avalo Therapeutics, Inc. (AVTX) | Director | Buy | 3,166 | $0 |
| 2026-01-08 | REGENXBIO Inc. (RGNX) | Chief Financial Officer | Buy | 73,749 | $0 |
| 2025-09-03 | REGENXBIO Inc. (RGNX) | Chief Financial Officer | Sell | 4,901 | $43,766 |
来源：SEC Form 4 申报文件 · 截至 2026-09-03